2024 Inova Fairfax MGR (Enduring Material): Update on SLE Classification, Treatment, and Complications

Topic: Update on SLE Classification, Treatment, and Complications

Learning Objectives

  • Advance education in basic scientific principles applicable to clinical situations.
  • Disseminate information regarding disease prevention and public health.
  • Improve understanding of psychosocial and legal issues as they apply to delivery of excellent patient care.
  • Provide updates in medical diagnosis and treatment to improve patient outcome.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
Course opens: 
03/26/2024
Course expires: 
03/25/2025
Cost:
$0.00
Part of: 
2024 Inova Fairfax Medicine Grand Rounds (Enduring Material)
Rating: 
0
Speaker(s)

Michelle Petri, MD MPH

has a financial relationship (Consulting Fee) with Kira Pharmaceuticals;.
has a financial relationship (Grant Or Contract) with AstraZeneca;.
has a financial relationship (Consulting Fee) with Nexstone Immunology;.
has a financial relationship (Grant Or Contract) with GSK;.
has a financial relationship (Consulting Fee) with Sanofi;.
has a financial relationship (Consulting Fee) with Annexon Bio;.
has a financial relationship (Consulting Fee) with Tenet Medicines Inc;.
has a financial relationship (Consulting Fee) with Aurinia;.
has a financial relationship (Consulting Fee) with Caribou Biosciences;.
has a financial relationship (Consulting Fee) with Emergent Biosciences;.
has a financial relationship (Consulting Fee) with Horizon Therapeutics;.
has a financial relationship (Consulting Fee) with Idorsia Pharmaceuticals;.
has a financial relationship (Consulting Fee) with Merck EMD Serono;.
has a financial relationship (Grant Or Contract) with Exagen;.
has a financial relationship (Consulting Fee) with Regeneron Pharmaceuticals;.
has a financial relationship (Consulting Fee) with AnaptysBio;.
has a financial relationship (Consulting Fee) with Takeda;.
has a financial relationship (Consulting Fee) with AstraZeneca;.
has a financial relationship (Consulting Fee) with Zydus;.
has a financial relationship (Consulting Fee) with Cabeletto Bio;.
has a financial relationship (Consulting Fee) with Escient Pharmaceuticals;.
has a financial relationship (Consulting Fee) with GSK;.
has a financial relationship (Consulting Fee) with IQVIA;.
has a financial relationship (Consulting Fee) with MedShr;.
has a financial relationship (Grant Or Contract) with Eli Lilly;.
has a financial relationship (Consulting Fee) with Proviant;.
has a financial relationship (Consulting Fee) with Amgen;.
has a financial relationship (Consulting Fee) with Sinomab Biosciences;.
has a financial relationship (Other) with Arthros-FocusMedEd;.
has a financial relationship (Consulting Fee) with UCB;.
has a financial relationship (Consulting Fee) with Boxer Capital;.
has a financial relationship (Consulting Fee) with CVS Health;.
has a financial relationship (Consulting Fee) with Gentibio;.
has a financial relationship (Consulting Fee) with Eli Lilly;.
has a financial relationship (Grant Or Contract) with Aurinia;.
has a financial relationship (Consulting Fee) with Nimbus Lakshmi;.
has a financial relationship (Grant Or Contract) with Janssen;.
has a financial relationship (Consulting Fee) with Seismic Therapeutic;.
has a financial relationship (Consulting Fee) with Argenx;.
has a financial relationship (Consulting Fee) with TG Therapeutics;.
has a financial relationship (Consulting Fee) with Axdev;.
has a financial relationship (Consulting Fee) with CTI Clinical Trial and Consulting Services;.
has a financial relationship (Consulting Fee) with Exo Therapeutics;.
has a financial relationship (Consulting Fee) with iCell Gene Therapeutics;.

Accreditation Statement

The Medical Society of Virginia is a member of the Southern States CME Collaborative, an ACCME Recognized Accreditor. Inova Health System Office of Continuing Medical Education is accredited by the Southern States CME Collaborative to provide continuing medical education for physicians.

Credit Designation Statement

The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 1.0 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency an

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.